Compare Johnson & Johnson (JNJ) vs Direxion Daily Semiconductor Bear 3X Shares (SOXS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Johnson & Johnson vs Direxion Daily Semiconductor Bear 3X Shares — how do they compare? Johnson & Johnson trades at $249.3 (market cap $598.96B), while Direxion Daily Semiconductor Bear 3X Shares trades at $44.77. The key difference: Johnson & Johnson pays a 2.15% dividend while Direxion Daily Semiconductor Bear 3X Shares pays none. Which is the better fit depends on your goals.
| JNJ | SOXS | |
|---|---|---|
Market Cap | $598.96B | — |
Volume | 6,156,228 | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $267.24 | $1.61K |
52-Week Low | $164.36 | $32.50 |
Enterprise Value | $631.90B | — |
Dividend Yield | 2.15% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Johnson & Johnson (JNJ) trades at $249.58, down 1.37% today, amid a generally bullish technical outlook with strong moving average signals. The company reported robust Q2 2026 earnings, beating EPS estimates and raising full-year guidance, with revenue growth to $94.19B in 2025 and a net income margin of 21.48%. Recent news highlights strong institutional interest and positive analyst sentiment, though the stock faces pressure from MedTech segment misses despite overall strength.
The outlook for JNJ remains positive, supported by solid fundamentals, a consistent dividend history, and upward revised earnings guidance. Key risks include competitive pressures in pharmaceuticals, regulatory hurdles, and execution challenges in the MedTech division. With a consensus price target of $279.33, representing ~12% upside, the stock offers a compelling opportunity for long-term investors, balanced by sector-specific volatility and macroeconomic factors.
SOXS, the Direxion Daily Semiconductor Bear 3X ETF, trades at $53.99, down 1.64% today, reflecting its inverse leveraged exposure to semiconductor stocks. Technical indicators show a bullish moving average signal but bearish oscillators with RSI levels above 96 suggesting extreme overbought conditions. Recent news highlights SOXS surging during semiconductor sell-offs, with a 1:10 stock split scheduled for July 26, 2026. The fund is designed for short-term tactical trades amid sector volatility.
The outlook for SOXS remains highly speculative, offering potential gains during semiconductor downturns but carrying significant decay and volatility risks. Investors should be cautious as the ETF is not suitable for long-term holdings due to its daily reset structure and inverse leverage, which can lead to substantial losses in rising markets.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →About Direxion Daily Semiconductor Bear 3X Shares
SOXS is a leveraged ETF that seeks daily investment results corresponding to 300% of the inverse (opposite) of the daily performance of the ICE Semiconductor Index. It is designed as a tactical tool for experienced traders to take a bearish (short) position on the semiconductor sector. Due to the effects of compounding and leverage, SOXS is intended to be held for a single day and is not suitable for long-term investment.
Read more on SOXS →
